EXICURE, Inc. (XCUR) intrinsic value & 10-year financials

EXICURE, Inc. (XCUR) has a Graham intrinsic value of $6.07 per share. At $1.12 on Oct 17, 2026, the stock trades 82% below that value. Over the last 10 fiscal years revenue shrank 8.7% a year to $0, with an average return on invested capital of 331.6%.

Graham intrinsic value
$6.07
Share price (Oct 17, 2026)
$1.12
Price vs Graham value
82% below
Market cap
$7.1M
Revenue (FY2025)
$0
Revenue growth (10-yr CAGR)
-8.7%
ROIC (10-yr avg)
331.6%
Free cash flow (FY2025)
-$8.6M

XCUR 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $0 -$4.9M -$0.79 -$8.6M — 2187.8%
FY2024 $500.0K -$9.7M -$1.58 -$2.9M -2446.4% -316.4%
FY2023 $0 -$16.9M -$0.70 -$10.4M — -140.4%
FY2022 $28.8M -$2.6M -$0.19 -$35.7M -6.4% -92.1%
FY2021 -$483.0K -$64.1M -$0.24 -$35.8M 12950.1% -286.5%
FY2020 $16.6M -$24.7M -$0.09 -$42.4M -153.1% -56.5%
FY2019 $1.3M -$26.3M — $235.0K -2053.8% -144.2%
FY2018 $118.0K -$22.4M — -$19.6M -18490.7% 1854.6%
FY2017 $9.7M -$12.0M — -$20.7M -117.7% 169.8%
FY2016 $1.0M -$16.9M — -$5.4M -1560.0% 140.4%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

EXICURE, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

EXICURE, INC. has historically struggled to out-earn its cost of capital, averaging just -25.7% ROIC.

Over the decade, EXICURE, INC. shows that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, EXICURE, INC. is modeled at -8.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $6.07 per share.

XCUR stock: frequently asked questions

What is the intrinsic value of EXICURE, Inc. (XCUR) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a -8.7% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, XCUR's intrinsic value is about $6.07 per share.

Is XCUR stock undervalued?

At $1.12 (close on Oct 17, 2026), XCUR trades 82% below its Graham value of $6.07. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has EXICURE, Inc. grown?

Revenue went from $1.0M in fiscal 2016 to $0 in fiscal 2025, a compound annual growth rate of -8.7%. Net income was -$4.9M in fiscal 2025.

Does EXICURE, Inc. generate free cash flow?

EXICURE, Inc. generated -$8.6M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 1 of the last 10 reported years.

What is XCUR's return on invested capital?

Average ROIC over the last 10 fiscal years was 331.6%, and average return on equity was -167.8%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this XCUR data come from?

From EXICURE, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 29, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks